Asset profile
Azacitidine
Small molecule
Partialdesign only
Evidence outlook · results not reported
NCT00887068 · Leukemia, AML, MDS
The lead study's design has limits that temper confidence (see the rationale below), and its results have not been reported. This tier describes the design, not an outcome.
NCT00887068: The study was randomized and controlled, with 87 participants assigned to azacitidine and 94 to observation, but it was open-label rather than blinded. Its primary clinical endpoint, relapse-free survival, had a numerically favorable result for azacitidine. Results were not posted at the time of grading; the key result shown was recorded subsequently from the registry record.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
61 competitors in this universe: 0 direct rivals (same mechanism and indication), 1 same-class, 60 same-indication; 11 further along in development.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Azacitidine: this drug | Phase 3 | Small molecule | DNMT1 (DNA methyltransferase 1) | ||
| Decitabine / Tetrahydrouridine (NDec) | Phase 2 | — | DNMT1 (DNA methyltransferase 1) | ||
| ASTX727 | Approved | Small molecule | Decitabine/cedazuridine fixed combination (DNMT + CDA inhibition) | ||
| Enasidenib | Approved | Small molecule | IDH2 | ||
| Gemtuzumab Ozogamicin | Approved | Antibody–drug conjugate | CD33 | ||
| Gilteritinib | Approved | Small molecule | FLT3 | ||
| Midostaurin | Approved | Small molecule | FLT3;KIT;PKC;PDGFR | ||
| Olutasidenib | Approved | Small molecule | Mutant IDH1 | ||
| Quizartinib | Approved | Small molecule | FLT3 | ||
| Revumenib | Approved | Small molecule | Menin | ||
| Tretinoin (Vesanoid) | Approved | Small molecule | RARA (retinoic acid receptor alpha); degrades the PML-RARA fusion oncoprotein in APL | ||
| Venetoclax | Approved | Small molecule | BCL-2 | ||
| Vyxeos | Approved | Small molecule | DNA synthesis (cytarabine, antimetabolite) / Topoisomerase II | ||
| 131I-Apamistamab | Phase 3 | Monoclonal antibody | CD45 | ||
| AK117 | Phase 3 | Monoclonal antibody | CD47 | ||
| APG-2575(Lisaftoclax ) | Phase 3 | Small molecule | BCL-2 |
…and 46 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(217 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (34)
October 2026 (3)
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-10-30 · NCT05453903 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2026-10-30 · NCT07490288 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-10-31 · NCT06741722 · CT.gov ↗
What to watch
November 2026 (4)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-11 · NCT03850574 · CT.gov ↗
What to watch
Phase 1Myelodysplastic Syndromes, MDS/MPN Crossover SyndromesRecruiting
Est. primary completion 2026-11-01 · NCT04187703 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-11-15 · NCT05226455 · CT.gov ↗
What to watch
Phase 2Plasmacytoma, Plasmacytoma of Bone, Multiple MyelomaActive not recruiting
Est. primary completion 2026-11-19 · NCT04174196 · CT.gov ↗
What to watch
December 2026 (27)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT05788679 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT05955261 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT06066905 · CT.gov ↗
What to watch
Phase 2Relapsed Classic Hodgkin Lymphoma, Refractory Classic Hodgkin LymphomaRecruiting
Est. primary completion 2026-12 · NCT06190067 · CT.gov ↗
What to watch
Phase 1Cerebral Palsy, ContractureEnrolling by invitation
Est. primary completion 2026-12 · NCT06377085 · CT.gov ↗
What to watch
Phase 1Leukemia, Myeloid Leukemia, Monocytic LeukemiaRecruiting
Est. primary completion 2026-12 · NCT06429449 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT06783790 · CT.gov ↗
What to watch
Phase 2NK/T Cell LymphomaRecruiting
Est. primary completion 2026-12 · NCT07000617 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12 · NCT07303660 · CT.gov ↗
What to watch
Phase 2T-cell Acute Lymphoblastic Leukemia, RecruitingRecruiting
Est. primary completion 2026-12-01 · NCT05376111 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-01 · NCT06220162 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-01 · NCT06635681 · CT.gov ↗
What to watch
Phase 1/2CML,Blast PhaseRecruiting
Est. primary completion 2026-12-01 · NCT06757855 · CT.gov ↗
What to watch
Phase 2Safety, Antitumor Activity, PK ProfileActive not recruiting
Est. primary completion 2026-12-01 · NCT06858618 · CT.gov ↗
What to watch
Phase 1/2Hematologic MalignanciesRecruiting
Est. primary completion 2026-12-30 · NCT04588922 · CT.gov ↗
What to watch
Phase 2Peripheral T Cell Lymphoma, Epigenetic RepressionRecruiting
Est. primary completion 2026-12-30 · NCT05958719 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-30 · NCT06451861 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-12-31 · NCT00392353 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2026-12-31 · NCT04128501 · CT.gov ↗
What to watch
Phase 2Myeloproliferative NeoplasmRecruiting
Est. primary completion 2026-12-31 · NCT05074355 · CT.gov ↗
What to watch
Phase 1/2T Cell LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT05230680 · CT.gov ↗
What to watch
Phase 2Hodgkin's LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT05355051 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT05584761 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT05603884 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2026-12-31 · NCT06345365 · CT.gov ↗
What to watch
Phase 1Myelodysplastic SyndromesRecruiting
Est. primary completion 2026-12-31 · NCT06502145 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2026-12-31 · NCT07486479 · CT.gov ↗
What to watch
2027 (84)
January 2027 (8)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01 · NCT05317403 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-01 · NCT06384261 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01 · NCT06773208 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-01-01 · NCT04801797 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-01-01 · NCT06754540 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01-16 · NCT06763341 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-01-31 · NCT03862157 · CT.gov ↗
What to watch
Phase 4Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-01-31 · NCT06370000 · CT.gov ↗
What to watch
February 2027 (3)
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-02 · NCT04086264 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-02 · NCT05183035 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-02-28 · NCT03383575 · CT.gov ↗
What to watch
March 2027 (8)
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-03 · NCT05428969 · CT.gov ↗
What to watch
Phase 1Glioblastoma (GBM), Diffuse Midline Glioma (DMG), Astrocytoma, IDH-Mutant, Grade 4, Diffuse Hemispheric Glioma, H3 G34-Mutant …Enrolling by invitation
Est. primary completion 2027-03 · NCT06896110 · CT.gov ↗
What to watch
Phase 2/3Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma …Active not recruiting
Est. primary completion 2027-03-01 · NCT04799275 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-01 · NCT06372717 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-08 · NCT06357182 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-23 · NCT05287568 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-31 · NCT04068597 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-03-31 · NCT05554406 · CT.gov ↗
What to watch
April 2027 (4)
Phase 2Early T Acute Lymphoblastic Leukemia, T-Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T/Myeloid, NosRecruiting
Est. primary completion 2027-04-01 · NCT07012447 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-04-25 · NCT06498973 · CT.gov ↗
What to watch
Phase 1Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-04-27 · NCT05162976 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-04-30 · NCT03586609 · CT.gov ↗
What to watch
May 2027 (4)
Phase 2Breast Cancer Invasive, Early-stage Breast Cancer, High Risk Breast CarcinomaRecruiting
Est. primary completion 2027-05 · NCT04891068 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-05-15 · NCT04150887 · CT.gov ↗
What to watch
Phase 2Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma …Recruiting
Est. primary completion 2027-05-19 · NCT04803201 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-05-31 · NCT07548710 · CT.gov ↗
What to watch
June 2027 (4)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-06 · NCT06656494 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-06-30 · NCT04988555 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-06-30 · NCT06429098 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-06-30 · NCT07094464 · CT.gov ↗
What to watch
July 2027 (7)
Phase 3Myelodysplastic Syndrome (MDS)Active not recruiting
Est. primary completion 2027-07 · NCT04401748 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-07 · NCT06090786 · CT.gov ↗
What to watch
Phase 1/2Chronic Myelomonocytic LeukemiaRecruiting
Est. primary completion 2027-07 · NCT06159491 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2027-07-01 · NCT05772273 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-07-01 · NCT06445907 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-07-04 · NCT04227847 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-07-30 · NCT03843528 · CT.gov ↗
What to watch
August 2027 (4)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08-01 · NCT06532552 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-08-05 · NCT06651229 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08-27 · NCT06616636 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-08-30 · NCT07132684 · CT.gov ↗
What to watch
September 2027 (11)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09 · NCT07761533 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-01 · NCT07743112 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaEnrolling by invitation
Est. primary completion 2027-09-01 · NCT07813390 · CT.gov ↗
What to watch
Phase 1Chronic Myeloid Leukemia, MyelofibrosesRecruiting
Est. primary completion 2027-09-04 · NCT03326310 · CT.gov ↗
What to watch
Phase 1/2Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome …Active not recruiting
Est. primary completion 2027-09-11 · NCT04734990 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-20 · NCT03683433 · CT.gov ↗
What to watch
Phase 2Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic SyndromeActive not recruiting
Est. primary completion 2027-09-30 · NCT02530463 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT03471260 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT05401097 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-09-30 · NCT07514936 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-09-30 · NCT07722767 · CT.gov ↗
What to watch
October 2027 (9)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10 · NCT06511882 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10 · NCT06634394 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-10 · NCT07486726 · CT.gov ↗
What to watch
Early phase / not applicableMyeloid TumorsNot yet recruiting
Est. primary completion 2027-10-01 · NCT07632170 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10-11 · NCT06504459 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-10-15 · NCT05907057 · CT.gov ↗
What to watch
Phase 2T-cell Acute Lymphoblastic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, RelapseRecruiting
Est. primary completion 2027-10-30 · NCT06686108 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-10-31 · NCT06497062 · CT.gov ↗
What to watch
Phase 1/2Atypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm …Recruiting
Est. primary completion 2027-10-31 · NCT06523556 · CT.gov ↗
What to watch
November 2027 (4)
Phase 4Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11 · NCT07044687 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-11-01 · NCT04256317 · CT.gov ↗
What to watch
Phase 3Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)Recruiting
Est. primary completion 2027-11-01 · NCT06465953 · CT.gov ↗
What to watch
Phase 2Higher Risk Myelodysplastic SyndromesNot yet recruiting
Est. primary completion 2027-11-30 · NCT07672769 · CT.gov ↗
What to watch
December 2027 (18)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12 · NCT04581512 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-12 · NCT06470841 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12 · NCT07255872 · CT.gov ↗
What to watch
Phase 3Peripheral T-cell Lymphoma Targeted TherapyEnrolling by invitation
Est. primary completion 2027-12-01 · NCT05678933 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-01 · NCT06548230 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2027-12-01 · NCT06744556 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-01 · NCT07304011 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-30 · NCT06386302 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT03874052 · CT.gov ↗
What to watch
Phase 1/2Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Recurrent Chronic Myelomonocytic Leukemia …Active not recruiting
Est. primary completion 2027-12-31 · NCT04493138 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT05270200 · CT.gov ↗
What to watch
Phase 2Myelodysplastic Syndromes, Myeloproliferative Chronic Myelomonocytic LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT05365035 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT05554393 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT05641259 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2027-12-31 · NCT07548983 · CT.gov ↗
What to watch
Phase 2Newly Diagnosed Mixed Phenotype Acute LeukemiaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07573670 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07748455 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07828535 · CT.gov ↗
What to watch
2028 (53)
January 2028 (5)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01 · NCT07392242 · CT.gov ↗
What to watch
Phase 1/2Peripheral T-cell Lymphoma (PTCL)Not yet recruiting
Est. primary completion 2028-01 · NCT07706959 · CT.gov ↗
What to watch
Phase 2DLBCL - Diffuse Large B Cell LymphomaNot yet recruiting
Est. primary completion 2028-01-01 · NCT06778902 · CT.gov ↗
What to watch
Phase 2Peripheral T Cells Lymphoma (PTCL)Recruiting
Est. primary completion 2028-01-15 · NCT07372352 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2028-01-30 · NCT06265545 · CT.gov ↗
What to watch
February 2028 (7)
Phase 2/3Peripheral T Cell LymphomaRecruiting
Est. primary completion 2028-02-01 · NCT07389616 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-02-01 · NCT07407660 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-02-01 · NCT07439211 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-02-09 · NCT06456463 · CT.gov ↗
What to watch
Phase 2Myelodysplastic Syndromes, Leukemia, Myelomonocytic, ChronicActive not recruiting
Est. primary completion 2028-02-14 · NCT05201066 · CT.gov ↗
What to watch
Phase 2Myeloid MalignancyRecruiting
Est. primary completion 2028-02-20 · NCT03850418 · CT.gov ↗
What to watch
Phase 1Solid Tumor, Locally Advanced Solid Tumor, Metastatic TumorRecruiting
Est. primary completion 2028-02-28 · NCT07404332 · CT.gov ↗
What to watch
March 2028 (3)
Phase 1Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Overlap Neoplasms, Chronic Neutrophilic LeukemiaRecruiting
Est. primary completion 2028-03-05 · NCT07071155 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-03-31 · NCT07469046 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-03-31 · NCT07507825 · CT.gov ↗
What to watch
April 2028 (3)
Phase 1/2Peripheral T Cells Lymphoma (PTCL)Recruiting
Est. primary completion 2028-04 · NCT07018752 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-04-01 · NCT07514832 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-04-30 · NCT07779031 · CT.gov ↗
What to watch
May 2028 (5)
Phase 2Myelodysplastic SyndromesRecruiting
Est. primary completion 2028-05-01 · NCT07283900 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaRecruiting
Est. primary completion 2028-05-10 · NCT07131059 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-05-25 · NCT06389292 · CT.gov ↗
What to watch
Phase 4Angioimmunoblastic T-cell Lymphoma (AITL)Active not recruiting
Est. primary completion 2028-05-26 · NCT07046182 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-05-31 · NCT07664839 · CT.gov ↗
What to watch
June 2028 (7)
Phase 2/3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-06 · NCT05404906 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-06 · NCT06668558 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-06 · NCT07471841 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-06-01 · NCT07642453 · CT.gov ↗
What to watch
Phase 2Squamous Cell Carcinoma of Head and NeckRecruiting
Est. primary completion 2028-06-30 · NCT05317000 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-06-30 · NCT05834244 · CT.gov ↗
What to watch
July 2028 (6)
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-07 · NCT07605949 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-07-02 · NCT05292664 · CT.gov ↗
What to watch
Phase 2/3Myelodysplastic SyndromesActive not recruiting
Est. primary completion 2028-07-31 · NCT05469737 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-07-31 · NCT05520567 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2028-07-31 · NCT06664879 · CT.gov ↗
What to watch
Phase 2Peripheral T-Cell LymphomaNot yet recruiting
Est. primary completion 2028-07-31 · NCT07746245 · CT.gov ↗
What to watch
August 2028 (1)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-08-31 · NCT04771130 · CT.gov ↗
What to watch
September 2028 (5)
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-09 · NCT04501120 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-09-01 · NCT04140487 · CT.gov ↗
What to watch
Phase 1/2Relapsed Peripheral T-Cell Lymphomas, Refractory Peripheral T-Cell LymphomasRecruiting
Est. primary completion 2028-09-01 · NCT06176027 · CT.gov ↗
What to watch
Phase 2Adult T-cell Leukemia/LymphomaRecruiting
Est. primary completion 2028-09-01 · NCT07159620 · CT.gov ↗
What to watch
Phase 1Myeloproliferative NeoplasmNot yet recruiting
Est. primary completion 2028-09-01 · NCT07679334 · CT.gov ↗
What to watch
October 2028 (1)
Phase 2/3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-10-01 · NCT07425808 · CT.gov ↗
What to watch
November 2028 (1)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-11-01 · NCT06557421 · CT.gov ↗
What to watch
December 2028 (9)
Phase 1/2Leukemia, Juvenile Myelomonocytic, JMML, JCML, Neurofibromatosis 1, CBL SyndromeRecruiting
Est. primary completion 2028-12 · NCT05849662 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12 · NCT06014489 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-12 · NCT07060001 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-12-11 · NCT07646821 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2028-12-15 · NCT06841952 · CT.gov ↗
What to watch
Phase 1Refractory Acute Leukemia, Pediatric RelapsedRecruiting
Est. primary completion 2028-12-31 · NCT06397027 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT07148180 · CT.gov ↗
What to watch
Phase 2Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative NeoplasmRecruiting
Est. primary completion 2028-12-31 · NCT07148947 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2028-12-31 · NCT07177079 · CT.gov ↗
What to watch
2029 (23)
January 2029 (2)
February 2029 (1)
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-02-01 · NCT07407140 · CT.gov ↗
What to watch
March 2029 (1)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-03-31 · NCT06782542 · CT.gov ↗
What to watch
April 2029 (1)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-04 · NCT06696183 · CT.gov ↗
What to watch
May 2029 (3)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-05-15 · NCT05564390 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-05-15 · NCT06317649 · CT.gov ↗
What to watch
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-05-31 · NCT07635485 · CT.gov ↗
What to watch
June 2029 (4)
Phase 3Higher-risk Myelodysplastic SyndromeRecruiting
Est. primary completion 2029-06 · NCT06641414 · CT.gov ↗
What to watch
Early phase / not applicableComplete Remission Rate， CRR, Progression Free Survival, Overall Survival, Adverse Event, Duration of ResponseNot yet recruiting
Est. primary completion 2029-06-01 · NCT07542912 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-06-22 · NCT06852222 · CT.gov ↗
What to watch
Phase 2Myelodysplastic Neoplasms, TransplantationRecruiting
Est. primary completion 2029-06-30 · NCT07047183 · CT.gov ↗
What to watch
July 2029 (1)
Early phase / not applicableAcute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-07 · NCT07762508 · CT.gov ↗
What to watch
September 2029 (2)
October 2029 (1)
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2029-10-01 · NCT07755202 · CT.gov ↗
What to watch
November 2029 (1)
Phase 1Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular Helper T-Cell Lymphoma …Not yet recruiting
Est. primary completion 2029-11-24 · NCT07691450 · CT.gov ↗
What to watch
December 2029 (6)
Phase 2/3Acute Myeloid LeukemiaEnrolling by invitation
Est. primary completion 2029-12 · NCT07651163 · CT.gov ↗
What to watch
Phase 2/3Acute Myeloid LeukemiaEnrolling by invitation
Est. primary completion 2029-12 · NCT07651176 · CT.gov ↗
What to watch
Phase 2LALNot yet recruiting
Est. primary completion 2029-12-01 · NCT07522801 · CT.gov ↗
What to watch
Phase 1/2PTCL, RefractoryNot yet recruiting
Est. primary completion 2029-12-12 · NCT07493330 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2029-12-12 · NCT07508982 · CT.gov ↗
What to watch
Phase 2NK T-Cell LymphomaNot yet recruiting
Est. primary completion 2029-12-30 · NCT07276698 · CT.gov ↗
What to watch
2030 (19)
January 2030 (1)
Phase 1Peripheral T-Cell Lymphoma RefractoryRecruiting
Est. primary completion 2030-01-01 · NCT07598578 · CT.gov ↗
What to watch
April 2030 (4)
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-04 · NCT05735184 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-04 · NCT07478991 · CT.gov ↗
What to watch
Phase 3Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-04-01 · NCT07539818 · CT.gov ↗
What to watch
Phase 1/2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-04-30 · NCT07770698 · CT.gov ↗
What to watch
June 2030 (4)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-06 · NCT07078591 · CT.gov ↗
What to watch
Phase 2Myelodysplastic SyndromesRecruiting
Est. primary completion 2030-06 · NCT07238686 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-06-01 · NCT07672262 · CT.gov ↗
What to watch
Phase 1Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-06-17 · NCT07320235 · CT.gov ↗
What to watch
July 2030 (2)
August 2030 (2)
September 2030 (4)
Phase 2Acute Myeloid LeukemiaRecruiting
Est. primary completion 2030-09 · NCT05904106 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-09 · NCT06598384 · CT.gov ↗
What to watch
Phase 3Leukemia, B-Cell, Chronic, LeukemiaNot yet recruiting
Est. primary completion 2030-09 · NCT07082452 · CT.gov ↗
What to watch
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-09 · NCT07463768 · CT.gov ↗
What to watch
October 2030 (1)
Phase 2Acute Myeloid LeukemiaActive not recruiting
Est. primary completion 2030-10-31 · NCT04062266 · CT.gov ↗
What to watch
December 2030 (1)
Phase 2Acute Myeloid LeukemiaNot yet recruiting
Est. primary completion 2030-12-31 · NCT05554419 · CT.gov ↗
What to watch
2031 (2)
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.